We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Genotyping Chip Accelerates Workflow and Increases Throughput While Maintaining Accuracy

By LabMedica International staff writers
Posted on 23 May 2011
Biotech and life science researchers now have the option of upgrading to an ultrafast genotyping system capable of providing 4,608 data points in just one hour.

The Fluidigm Corporation (South San Francisco, CA, USA) has introduced its new 192.24 Dynamic Array IFC (integrated fluidic circuit) array chip. More...
This microarray was designed to genotype 192 samples against 24 SNP (single nucleotide polymorphism) assays in a single run, providing 4,608 data points in just one hour.

Dynamic Array IFCs have an on-chip network of microfluidic channels, chambers, and valves that automatically assemble individual PCR reactions, decreasing the number of pipetting steps required by up to 100-fold. This accelerated workflow and increased throughput enables more data points, while the 192.24 chip retains Fluidigm's 99.75% or greater call accuracy and 99% or greater call rates.

The new chip can be read using either Fluidigm's BioMark HD (the BioMark HD system is the newest real-time PCR system developed by Fluidigm with enhanced productivity, increased reliability, and a smaller footprint) or EP1 (the EP1 system offers the most efficient system for high sample throughput SNP genotyping and other applications using end-point reading after PCR) systems.

"The Fluidigm 192.24 Dynamic Array chip enables life science researchers to achieve ultra-low cost, and rapid throughput while maintaining full assay and reagent flexibility. Providing the ability to use fewer SNP assays, and run a high number of samples is a format that is ideal for some applications in agricultural biochemistry and for GWAS (genome wide association) follow-up studies," said Gajus Worthington, Fluidigm president and CEO.

Related Links:
Fluidigm Corporation




Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
New
Fully Automated Urinalysis System
DxU 1800 Fully Automated Urinalysis System
Thyroid Test
Anti-Thyroid EIA Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers developed three mathematical biomarkers from routine PSA blood tests that may help predict early prostate cancer treatment outcomes and personalize adaptive therapy (Image Credit: Adobe Stock)

Mathematical Biomarkers Use Routine Blood Tests to Guide Adaptive Prostate Cancer Therapy

Personalizing systemic therapy for prostate cancer remains challenging because tumors can evolve under treatment pressure, driving resistance and early relapse. Continuous high-dose regimens may initially... Read more

Molecular Diagnostics

view channel
Image: The duet mosaic family comprises duet +modC mosaic and duet 6-base mosaic, two cfDNA-optimized multiomic sequencing workflows for liquid biopsy and translational research. (Photo courtesy of bimodal)

New Liquid Biopsy Workflow Maximizes Tumor Signals from Limited Blood Samples

Liquid biopsy seeks to detect tumor-derived signals from small blood samples, but circulating cell-free DNA is scarce and heterogeneous, limiting sensitivity. Combining complementary signals such as methylation,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.